Burzynski Research Institute
FDA inspection history in Houston, Texas, 2002 to 2013
- 1
- Response
- 1
- Form 483
- 1
- Warning letter
Every document, by year
- Response
- Form 483
- Warning letter
2002: one warning letter; 2013: one warning letter response and one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2002One warning letter, at Houston, Texas.
- 2013One warning letter response and one Form 483, at Houston, Texas.
Cited most
Across all Burzynski Research Institute observations on file
- 21 CFR 312.53(c)(4)Selecting investigators and monitors1
- 21 CFR 312.56(a)Review of ongoing investigations1
The complete Burzynski Research Institute file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Houston, Texas
One warning letter response, one Form 483 and one warning letter · 2002 to 2013 · 2 observations
Latest: Response, Dec 23, 2013 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2013-12-23 | Response Warning letter response | Houston, Texas | — | $199 |
| 2013-03-15 | 483 Form 483 | Houston, Texas | 2 | $99 |
| 2002-04-29 | Warning letter Warning letter | Houston, Texas | — | $99 |
Investigators on these documents
Joel Martinez (2)Cynthia F. Kleppinger (1)Hugh M. McClure (1)Patrick Stone (1)
FEI number 3005553411 · most recent document Dec 23, 2013
About Burzynski Research Institute
How many FDA Form 483s has Burzynski Research Institute received?
FDA Intel has 1 Form 483 on file for Burzynski Research Institute; the most recent is dated Mar 15, 2013.
When was Burzynski Research Institute last inspected by FDA?
The most recent FDA inspection document on file for Burzynski Research Institute is a Form 483 dated Mar 15, 2013, for the site in Houston, Texas.
What did FDA cite at Burzynski Research Institute?
The regulations cited most in the observations on file for Burzynski Research Institute are 21 CFR 312.53(c)(4) (Selecting investigators and monitors), 1 time; 21 CFR 312.56(a) (Review of ongoing investigations), 1 time.
Has Burzynski Research Institute received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Burzynski Research Institute; the most recent is dated Apr 29, 2002.